{
    "Trade/Device Name(s)": [
        "vWF Ag"
    ],
    "Submitter Information": "Siemens Healthcare Diagnostics Products GmbH",
    "510(k) Number": "K220728",
    "Predicate Device Reference 510(k) Number(s)": [
        "K962675"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "GGP"
    ],
    "Summary Letter Date": "February 10, 2023",
    "Summary Letter Received Date": "February 10, 2023",
    "Submission Date": "June 2, 2023",
    "Regulation Number(s)": [
        "21 CFR 864.7290"
    ],
    "Regulation Name(s)": [
        "Factor Deficiency Test"
    ],
    "Analyte Class(es)": [
        "hematology",
        "coagulation"
    ],
    "Analyte(s)": [
        "von Willebrand antigen (VWF:Ag)"
    ],
    "Specimen Type(s)": [
        "Plasma"
    ],
    "Specimen Container(s)": [
        "3.2% sodium citrated tube"
    ],
    "Instrument(s)/Platform(s)": [
        "SYSMEX CS-2500 analyzer"
    ],
    "Method(s)/Technology(ies)": [
        "Immunoturbidimetric assay"
    ],
    "Methodologies": [
        "Quantitative measurement",
        "Turbidimetry"
    ],
    "Submission Type(s)": [
        "Assay",
        "Reagent",
        "Calibrator",
        "Buffer",
        "Diluent"
    ],
    "Document Summary": "FDA 510(k) summary for Siemens vWF Ag immunoturbidimetric assay for quantitative measurement of von Willebrand antigen in human plasma using the SYSMEX CS-2500 analyzer",
    "Indications for Use Summary": "In vitro diagnostic automated assay for quantitative determination of von Willebrand antigen in human plasma from venous blood samples in sodium citrated tubes on the SYSMEX CS-2500 analyzer, aiding evaluation of patients (age 4 weeks and older) with suspected or confirmed von Willebrand factor disorders for prescription use",
    "fda_folder": "Hematology"
}